Classes & Events News Feedback Donate

Using groundbreaking studies to drive effective, new cancer treatments is the core principle of research at Atlantic Health System Cancer Care. In addition to featuring many of the nation’s top doctors and researchers, we have partnerships with industry and cooperative groups that allow us to provide our communities with the latest cancer clinical trials.

Bonni Guerin cancer research

Pioneers in Cancer Research

With many of our clinical trials, such as our treatments for gioblastoma and HPV-associated cancers, we are one of only a handful of sites in the country offering them. Other accomplishments include:

  • The Atlantic Melanoma Center was the first in the world to enroll a patient in a Phase IIa trial of a virus-based immunotherapy.
  • Overlook Medical Center enrolled the most patients in the region (NJ, NY, CT, PA and DE) into the international TAILORx breast cancer study.
  • The Women’s Cancer Center was one of six centers in the nation to participate in an MD Andersen Cancer Center clinical trial for the early detection of ovarian cancer.
  • Atlantic Health System was the first health system selected by Translational Genomics Research Institute and Origin to create the Breakthrough Oncology Accelerator.

Request More Information

Please use the form to request more information.

All fields are required.

Please provide your first name
Please provide your last name
Please input a valid email address
Please provide your Phone number
Please provide your Zip code
Please Choose location
What are you interested in?:
Please provide an interest
Patient information
Please enter the patient's first name
Please enter the patient's last name

* Required
Researchers in the lab

Breakthrough Oncology Accelerator

Atlantic Health System and Translational Genomics Research Institute (TGen) have entered into a partnership knowing as the Breakthrough Oncology Accelerator, which will promote faster access to innovative cancer treatments and reduce financial barriers by developing new payment models.